We are live on ! Find out more
MC

Montag & Caldwell Portfolio holdings

AUM $457M
1-Year Est. Return 20.19%
This Fund
S&P 500
This Quarter Est. Return
+1.41%
1 Year Est. Return
+20.19%
3 Year Est. Return
+91.25%
5 Year Est. Return
+132.5%
10 Year Est. Return
+417.29%
AUM
$7.04B
AUM Growth
-$1.21B
Cap. Flow
-$1.31B
Cap. Flow %
-18.68%
Top 10 Hldgs %
38.9%
Holding
118
New
8
Increased
14
Reduced
76
Closed
16

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$231M
2
MON
Monsanto Co
MON
+$125M
3
GILD icon
Gilead Sciences
GILD
+$124M
4
BIIB icon
Biogen
BIIB
+$106M
5
MCK icon
McKesson
MCK
+$102M

Sector Composition

Rank Sector Weight
1 Healthcare 34.19%
2 Consumer Staples 21.48%
3 Consumer Discretionary 10.93%
4 Financials 9.47%
5 Industrials 7.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
V icon
1
Visa
V
$697B
$309M 4.39%
4,601,070
-783,159
-15% -$53.1M
PEP icon
2
PepsiCo
PEP
$195B
$307M 4.36%
3,285,991
-588,022
-15% -$56.2M
AGN
3
DELISTED
Allergan plc
AGN
$305M 4.34%
1,005,750
-179,254
-15% -$53.5M
MDLZ icon
4
Mondelez International
MDLZ
$80.2B
$297M 4.22%
7,211,340
-1,412,109
-16% -$55.4M
MCK icon
5
McKesson
MCK
$104B
$292M 4.15%
1,297,258
-439,605
-25% -$102M
ABT icon
6
Abbott
ABT
$187B
$256M 3.64%
5,219,893
-898,585
-15% -$43.1M
GILD icon
7
Gilead Sciences
GILD
$167B
$255M 3.62%
2,175,597
-1,137,871
-34% -$124M
SBUX icon
8
Starbucks
SBUX
$118B
$243M 3.46%
4,537,261
-1,978,235
-30% -$100M
TMO icon
9
Thermo Fisher Scientific
TMO
$214B
$240M 3.41%
1,851,060
-377,707
-17% -$49.2M
BIIB icon
10
Biogen
BIIB
$30.4B
$233M 3.31%
576,614
-263,826
-31% -$106M
DLTR icon
11
Dollar Tree
DLTR
$24.4B
$222M 3.16%
2,811,811
-107,170
-4% -$8.47M
EL icon
12
Estee Lauder
EL
$30.7B
$221M 3.14%
2,545,376
-415,444
-14% -$35.8M
WBA
13
DELISTED
Walgreens Boots Alliance
WBA
$210M 2.99%
2,489,414
-414,515
-14% -$35.7M
HON icon
14
Honeywell
HON
$78.3B
$203M 2.88%
2,210,485
+129,562
+6% +$12.1M
TJX icon
15
TJX Companies
TJX
$178B
$201M 2.86%
6,087,268
-1,313,892
-18% -$43.7M
ACN icon
16
Accenture
ACN
$101B
$196M 2.79%
2,025,581
-350,756
-15% -$33.5M
CCL icon
17
Carnival Corporation Ltd
CCL
$38.7B
$194M 2.75%
3,918,092
+2,556,761
+188% +$121M
CL icon
18
Colgate-Palmolive
CL
$74.2B
$193M 2.74%
2,945,160
-544,055
-16% -$36.9M
GOOG icon
19
Alphabet (Google) Class C
GOOG
$4.07T
$191M 2.72%
7,083,280
-1,492,300
-17% -$40M
CERN
20
DELISTED
Cerner Corp
CERN
$180M 2.56%
2,609,198
+214,581
+9% +$15M
CTSH icon
21
Cognizant
CTSH
$23.8B
$177M 2.52%
2,898,413
+97,219
+3% +$6.1M
DG icon
22
Dollar General
DG
$27.8B
$172M 2.45%
2,214,727
+713,648
+48% +$53.8M
META icon
23
Meta Platforms (Facebook)
META
$1.51T
$172M 2.44%
2,004,058
+133,602
+7% +$10.9M
AMGN icon
24
Amgen
AMGN
$212B
$166M 2.37%
1,084,064
-252,603
-19% -$40.5M
UPS icon
25
United Parcel Service
UPS
$89.7B
$166M 2.35%
1,709,249
+317,333
+23% +$31.5M

Similar funds

Montag & Caldwell's Q2 2015 Portfolio in Review

As of Q2 2015, Montag & Caldwell held 118 positions worth $7.04B, down 15% from $8.24B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Montag & Caldwell withdrew a net $1.31B in Q2 2015, closing 16 positions and reducing 76 holdings. Its most notable exit was American Express, an estimated $100M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 33% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, Montag & Caldwell opened a new position in Celgene Corp worth $152M.

  • Montag & Caldwell's largest Q2 2015 buy was Celgene Corp: 1,309,342 shares worth $152M.
  • Montag & Caldwell added most to Carnival Corporation Ltd in Q2 2015, an estimated $121M increase.
  • Montag & Caldwell's biggest Q2 2015 reduction was Procter & Gamble, cutting an estimated $231M.
  • Montag & Caldwell fully exited American Express in Q2 2015, selling an estimated $100M.
  • Montag & Caldwell's ten largest holdings make up 39% of its $7.04B portfolio in Q2 2015.
  • Montag & Caldwell opened 8 new positions and closed 16 in Q2 2015.
  • Montag & Caldwell's portfolio value fell 15% quarter-over-quarter to $7.04B.

Based on Montag & Caldwell's 13F filing for Q2 2015, filed 27 Jul 2015.